
Tejnaksh Healthcare Faces Market Assessment Shift Amidst Challenging Financial and Technical Trends
2025-12-04 08:14:52Tejnaksh Healthcare, a player in the healthcare services sector, has recently experienced a notable shift in market evaluation metrics. This change reflects a complex interplay of technical indicators, valuation considerations, financial trends, and quality assessments, highlighting the challenges the company faces amid a subdued market environment and persistent underperformance relative to benchmarks.
Read MoreWhy is Tejnaksh Health. falling/rising?
2025-12-04 00:48:39Extended Underperformance Against Benchmarks Tejnaksh Healthcare's recent price action reflects a persistent weakness relative to the Sensex and its sector peers. Over the past week, the stock has declined by 4.82%, markedly worse than the Sensex's modest 0.59% loss. The one-month performance further emphasises this divergence, with Tejnaksh Healthcare falling 11.76% while the Sensex gained 1.34%. Year-to-date figures reveal an even starker contrast: the stock has lost 30.70% of its value, whereas the Sensex has appreciated by 8.92%. This underperformance extends over longer horizons, with the stock down 34.73% over the last year and a staggering 73.93% over three years, while the Sensex has delivered positive returns of 5.27% and 35.37% respectively during these periods....
Read MoreHow has been the historical performance of Tejnaksh Health.?
2025-12-03 22:51:13Revenue and Profitability Trends Over the seven-year period ending March 2025, Tejnaksh Health.'s net sales demonstrated a downward trend from ₹19.76 crores in 2019 to ₹12.90 crores in 2025. The peak sales were recorded in 2019, followed by a notable decline in subsequent years, with a slight recovery in the latest fiscal year. Total operating income mirrored this pattern, reflecting the company’s core business activity without other operating income contributions, which remained nil throughout. Despite the decline in sales, the company managed to maintain a relatively stable operating profit margin, which stood at 31.63% in 2025, up from 21.15% in 2019. This improvement indicates enhanced operational efficiency or cost management. Operating profit (PBDIT) excluding ot...
Read More
Tejnaksh Healthcare Falls to 52-Week Low of Rs.16 Amid Continued Downtrend
2025-12-03 13:50:14Tejnaksh Healthcare’s stock price reached a fresh 52-week low of Rs.16 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past four consecutive sessions, reflecting ongoing pressures within the healthcare services sector.
Read More
Tejnaksh Healthcare Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals
2025-11-28 08:10:25Tejnaksh Healthcare, a player in the healthcare services sector, has experienced a notable revision in its market evaluation, reflecting a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments. This article analyses the factors influencing the recent shift in the company’s investment outlook, providing investors with a comprehensive understanding of its current position.
Read More
Tejnaksh Healthcare Stock Falls to 52-Week Low of Rs.16.02
2025-11-24 14:41:59Tejnaksh Healthcare has reached a new 52-week low, with its share price touching Rs.16.02 today. This marks a significant decline amid broader market fluctuations and ongoing challenges within the healthcare services sector.
Read More
Tejnaksh Healthcare Sees Adjustment in Evaluation Amid Technical and Financial Trends
2025-11-19 08:16:21Tejnaksh Healthcare, a key player in the Healthcare Services sector, has undergone a revision in its evaluation reflecting changes across technical indicators, financial trends, valuation metrics, and overall quality parameters. This article analyses the factors influencing the recent adjustment in the company’s score grade as of 19 Nov 2025, providing investors with a comprehensive overview of its current standing.
Read MoreHow has been the historical performance of Tejnaksh Health.?
2025-11-18 22:59:29Answer: The historical performance of Tejnaksh Health shows a fluctuating trend in net sales and profitability over the years. Breakdown: Tejnaksh Health's net sales increased from 11.73 Cr in Mar'23 to 12.90 Cr in Mar'25, showing a steady growth trend. However, this is a decline from a peak of 19.76 Cr in Mar'19. The total operating income followed a similar pattern, rising to 12.90 Cr in Mar'25 from 12.18 Cr in Mar'24, yet down from 16.76 Cr in Mar'20. The total expenditure, excluding depreciation, has gradually increased to 8.82 Cr in Mar'25 from 8.04 Cr in Mar'23, indicating rising operational costs. Operating profit (PBDIT) improved to 4.48 Cr in Mar'25 from 3.94 Cr in Mar'24, although it remains lower than the 5.73 Cr recorded in Mar'19. Profit before tax also rose to 3.19 Cr in Mar'25, up from 2.38 Cr in Mar'24, while profit after tax increased to 2.23 Cr in Mar'25 from 1.76 Cr in Mar'24. The compa...
Read MoreWhy is Tejnaksh Health. falling/rising?
2025-11-18 22:52:21As of 18-Nov, Tejnaksh Healthcare Ltd's stock price is currently at Rs 16.50, reflecting a decrease of Rs 0.27 or 1.61%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 3.34% during this period. It is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the stock is close to its 52-week low, just 1.82% away from Rs 16.2. While there has been a rise in investor participation, with delivery volume increasing by 28.9% against the 5-day average, the overall performance remains weak, as evidenced by the stock's year-to-date decline of 26.70% compared to the Sensex's gain of 8.36%. In the broader market context, Tejnaksh Healthcare's recent performance contrasts sharply with the benchmark Sensex, which has shown positive returns over various periods, including a 0.96% in...
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
18-Jan-2026 | Source : BSERespected Sir/Madam Please refer letter attached for your reference. Thanks Afrin Shaikh
Closure of Trading Window
28-Dec-2025 | Source : BSEPlease refer closure of trading window details attached
Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30Th September 2025
08-Nov-2025 | Source : BSEPlease find enclosed financial result for the quarter ended 30th September 2025
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
Tejnaksh Healthcare Ltd has announced 5:10 stock split, ex-date: 19 Jul 23
Tejnaksh Healthcare Ltd has announced 36:10 bonus issue, ex-date: 26 Apr 18
No Rights history available